Skip to main
NHI

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 50%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors is well-positioned for long-term success, with a strong portfolio of healthcare real estate assets and a focus on needs-driven and discretionary senior housing and skilled nursing facilities. Although recent transactions may result in a decline in annual NOI in the short-term, the company's use of 1031 exchanges and projections for future acquisitions and growth suggest potential for solid performance in the coming years. The risks of operator concentration and potential challenges related to deferred rent collections should be monitored, but overall, National Health Investors has a positive outlook for its fundamental performance.

Bears say

National Health Investors is facing significant changes to its portfolio composition and debt leverage after announcing plans to sell its entire 35-facility portfolio to National HealthCare Corporation (NHC). This will result in a reduction of operator concentration and an end to the company's relationship with NHC, but it will also result in a decrease in revenue and earnings. Additionally, the decision to sell rather than reset rents may have long-term benefits, but it is not the most financially advantageous option in the short term. The company's future success will depend heavily on its ability to successfully manage its remaining portfolio and invest in new growth opportunities.

NHI has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 50% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 4 analysts, NHI has a Buy consensus rating as of May 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $88.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $88.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.